Evidence map›Paper›PMID 28248246›Full record

ReviewProteomes2016

Let There Be Light!

Doroteya Raykova, Björn Koos, Anna Asplund, Márton Gelléri, Ylva Ivarsson, U Helena Danielson, Ola Söderberg

Abstract readReview
In one paragraph

Review in Proteomes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Analyzing the Integrin Adhesome by In Situ Proximity Ligation Assay.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Doroteya RaykovaDepartment of Pharmaceutical Biosciences, Pharmaceutical Cell Biology, Biomedical Center, Box 594, Uppsala University, SE-751 08 Uppsala, Sweden. doroteya.raykova@igp.uu.se.
Björn KoosDepartment of Systemic Cell Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany. bjoern.koos@mpi-dortmund.mpg.de.
Anna AsplundDepartment of Immunology, Genetics and Pathology, Dag Hamarskjölds väg 14B, Rudbeck Laboratory, Uppsala University, 751 85 Uppsala, Sweden. anna.asplund@igp.uu.se.
Márton GellériDepartment of Systemic Cell Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany. marton.gelleri@mpi-dortmund.mpg.de.
Ylva IvarssonDepartment of Chemistry-BMC, Box 576, Uppsala University, SE-751 23 Uppsala, Sweden. ylva.ivarsson@kemi.uu.se.
U Helena DanielsonDepartment of Chemistry-BMC, Box 576, Uppsala University, SE-751 23 Uppsala, Sweden. helena.danielson@kemi.uu.se.
Ola SöderbergDepartment of Pharmaceutical Biosciences, Pharmaceutical Cell Biology, Biomedical Center, Box 594, Uppsala University, SE-751 08 Uppsala, Sweden. ola.soderberg@igp.uu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The invention of the microscope has been fundamental for the understanding of tissue architecture and subcellular structures. With the advancement of higher magnification microscopes came the development of various molecular biology tools such as Förster resonance energy transfer (FRET) and

Indexed as

FREThigh resolution microscopyin situ PLApost-translational modificationsprotein–protein interactionsproxHCR

Identifiers

PMID28248246
PMCPMC5260969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.